Disruptions of the fornix fiber in parkinsonian patients with excessive daytime sleepiness

Parkinsonism and Related Disorders

Volumn 12, Issue 5, 2006, Pages 319-322

  Matsui, Hideaki ^a   Nishinaka, Kazuto ^a   Oda, Masaya ^a   Niikawa, Hidekazu ^a   Komatsu, Kenichi ^a   Kubori, Tamotsu ^a   Udaka, Fukashi ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Diffusion tensor imaging; Excessive daytime sleepiness; Fornix; Fractional anisotropy; Parkinson's disease

Indexed keywords

ADULT; AGED; ANISOTROPY; ARTICLE; BRAIN FORNIX; CLINICAL ARTICLE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ANISOTROPY; DATA INTERPRETATION, STATISTICAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FORNIX (BRAIN); HUMANS; MALE; NERVE DEGENERATION; NERVE FIBERS; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; SLEEP STAGES;

EID: 33744515010     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.01.007     Document Type: Article

References (23)

1. Olanow C.W., Watts R.L., and Koller W.C. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. Neurology 56 Suppl. 5 (2001) S1-S88
2. Lees A.J., Blackburn N.A., and Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11 (1988) 512-519
3. Frucht S., Rogers J.D., Greene P.E., Gordon M.F., and Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52 (1999) 1908-1910
4. Simuni T. Somnolence and other sleep disorders in Parkinson's disease: the challenge for the practicing neurologist. Neurol Clin 22 (2004) S107-S126
5. Ellis C.M., Simmons A., Jones D.K., Bland J., Dawson J.M., Horsfield M.A., Williams S.C., and Leigh P.N. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53 (1999) 1051-1058
6. Bozzali M., Falini A., Cercignani M., Baglio F., Farina E., Alberoni M., Vezzulli P., Olivotto F., Mantovani F., Shallice T., Scotti G., Canal N., and Nemni R. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain 128 (2005) 1595-1604
7. Schocke M.F., Seppi K., Esterhammer R., Kremser C., Mair K.J., Czermak B.V., Jaschke W., Poewe W., and Wenning G.K. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21 (2004) 1443-1451
8. Tievsky A.L., Ptak T., and Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 20 (1999) 1491-1499
9. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
10. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
11. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., and Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163 (1999) 94-98
12. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14 (1991) 540-545
13. Rye D.B., and Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58 (2002) 341-346
14. Ferreira J.J., Galitzky M., Thalamas C., Tiberge M., Montastruc J.L., Sampaio C., and Rascol O. Effect of ropinirole on sleep onset: a randomized placebo controlled study in healthy volunteers. Neurology 58 (2002) 460-462
15. The European agency for the evaluation of medicinal products; evaluation of medicines for human use. CPMP position statement: dopaminergic substances and sudden onset of sleep; 2002. Available at: http://www.emea.eu.int/pdfs/human/press/pos/057802.pdf
16. Fabbrini G., Barbanti P., Aurilia C., Vanacore N., Pauletti C., and Meco G. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 17 (2002) 1026-1030
17. Di Chiari G., Proceddu M.L., Varigu L., Argiolas A., and Gessa G.L. Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264 (1976) 564-567
18. Kiyashchenko L.I., Mileykovskiy B.Y., Maidment N., Lam H.A., Wu M.F., John J., Peever J., and Siegel J.M. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 22 (2002) 5282-5286
19. Drouot X., Moutereau S., Nguyen J.P., Lefaucheur J.P., Creange A., Remy P., Goldenberg F., and d'Ortho M.P. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61 (2003) 540-543
20. Langston J.W., and Forno L.S. The hypothalamus in Parkinson's disease. Ann Neurol 3 (1978) 129-133
21. Le Bihan D., Turner R., Douek P., and Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 159 (1992) 591-599
22. Pierpaoli C., and Basser P.J. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 36 (1996) 893-906
23. Abe O., Aoki S., Hayashi N., Yamada H., Kunimatsu A., Mori H., Yoshikawa T., Okubo T., and Ohtomo K. Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging 23 (2002) 433-441